- Home
- IMNM vs SHOO Comparison
IMNM vs SHOO Comparison
Compare IMNM & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | SHOO |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.7B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | IMNM | SHOO |
|---|---|---|
| Price | $21.92 | $36.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $32.10 | ★ $41.50 |
| AVG Volume (30 Days) | 1.0M | ★ 2.0M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | ★ 7.06 | 2.17 |
| EPS | N/A | ★ 0.30 |
| Revenue | $9,041,000.00 | ★ $2,282,927,000.00 |
| Revenue This Year | N/A | $13.02 |
| Revenue Next Year | $11.53 | $4.57 |
| P/E Ratio | ★ N/A | $119.40 |
| Revenue Growth | N/A | ★ 15.21 |
| 52 Week Low | $5.15 | $19.05 |
| 52 Week High | $27.65 | $46.88 |
Technical Indicators
Market Signals| Indicator | IMNM | SHOO |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 39.22 |
| Support Level | $18.98 | $36.20 |
| Resistance Level | $22.57 | $39.86 |
| Average True Range (ATR) | 1.18 | 1.82 |
| MACD | -0.31 | -0.13 |
| Stochastic Oscillator | 15.51 | 45.50 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.